Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Debt Repayments (2024)

Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Long-Term Debt Repayments came in at $345139.0 in Q3 2024.

Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Debt Repayments (2024) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at $345139.0 for Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 23.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -478.39 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Shuttle Pharmaceuticals Holdings 120,186.04 120,186.04 - -

Historic Data

Download Data
DateValue
Sep 30, 2024 345,139.00
Sep 30, 2024 345,139.00